Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 101
of 6Next
1:

Association of Epstein-Barr virus antibody titers with a human IL-10 promoter polymorphism in Japanese women.

Yasui Y, Hamajima N, Nakamura T, El-Din NS, Tajima K, Potter JD.

J Autoimmune Dis. 2008 Mar 4;5:2.

PMID: 18318911 [PubMed - in process]

2:

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.

Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A.

JAMA. 2005 May 25;293(20):2496-500.

PMID: 15914750 [PubMed - indexed for MEDLINE]

3:

Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.

De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A.

Neurology. 2008 Mar 25;70(13 Pt 2):1113-8. Epub 2008 Feb 13.

PMID: 18272866 [PubMed - indexed for MEDLINE]

4:

Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.

Hadar T, Rahima M, Kahan E, Sidi J, Rakowsky E, Sarov B, Sarov I.

J Med Virol. 1986 Dec;20(4):329-39.

PMID: 3025351 [PubMed - indexed for MEDLINE]

5:

Antiviral antibodies in the sera of homosexual men: correlation with their lifestyle and drug usage.

Nerurkar LS, Biggar RJ, Goedert JJ, Wallen W, Becker P, West F, Tzan N, Traub R, Lee YJ, Botelar W, et al.

J Med Virol. 1987 Feb;21(2):123-35.

PMID: 3029318 [PubMed - indexed for MEDLINE]

6:

Multiple sclerosis and Epstein-Barr virus.

Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A.

JAMA. 2003 Mar 26;289(12):1533-6. Retraction in: Ascherio A, Rubertone M, Spiegelman D, Levin L, Munger K, Peck C, Lennette E. JAMA. 2005 May 25;293(20):2466.

PMID: 12672770 [PubMed - indexed for MEDLINE]

7:

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.

Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernán MA, Olek MJ, Hankinson SE, Hunter DJ.

JAMA. 2001 Dec 26;286(24):3083-8.

PMID: 11754673 [PubMed - indexed for MEDLINE]

9:

Cancer risk to the gastric corpus in Japanese, its correlation with interleukin-1beta gene polymorphism (+3953*T) and Epstein-Barr virus infection.

Sakuma K, Uozaki H, Chong JM, Hironaka M, Sudo M, Ushiku T, Nagai H, Fukayama M.

Int J Cancer. 2005 May 20;115(1):93-7.

PMID: 15688413 [PubMed - indexed for MEDLINE]

10:

Enhanced antibody responses to Epstein-Barr virus in HIV-infected homosexual men.

Rahman MA, Kingsley LA, Breinig MK, Ho M, Armstrong JA, Atchison RW, Lyter DW, Rinaldo CR Jr.

J Infect Dis. 1989 Mar;159(3):472-9.

PMID: 2536790 [PubMed - indexed for MEDLINE]

11:

Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.

Masucci G, Mellstedt H, Masucci MG, Szigeti R, Ernberg I, Björkholm M, Tsukuda K, Henle G, Henle W, Pearson G, et al.

Cancer Res. 1984 Mar;44(3):1288-300.

PMID: 6318984 [PubMed - indexed for MEDLINE]

12:

Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype.

Parks CG, Cooper GS, Hudson LL, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Pandey JP.

Arthritis Rheum. 2005 Apr;52(4):1148-59.

PMID: 15818712 [PubMed - indexed for MEDLINE]

13:

Analysis of immune complexes in rheumatoid arthritis for Epstein-Barr virus antigens reveals cross-reactivity of viral capsid antigen and human IgG.

Inman RD, Chiu B, Hamilton NC.

J Immunol. 1987 Jan 15;138(2):407-12.

PMID: 3025298 [PubMed - indexed for MEDLINE]

14:

Epstein-Barr virus-associated antibody pattern in untreated non-Hodgkin lymphoma patients. Relationship to clinical variables and lymphocyte functions.

Lindemalm C, Biberfeld P, Björkholm M, Henle G, Henle W, Holm G, Johansson B, Klein G, Mellstedt H.

Int J Cancer. 1983 Dec 15;32(6):675-82.

PMID: 6317577 [PubMed - indexed for MEDLINE]

15:

Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia.

Dölken G, Bross KJ, Hecht T, Brugger W, Löhr GW, Hirsch FW.

Int J Cancer. 1986 Jul 15;38(1):55-9.

PMID: 3013785 [PubMed - indexed for MEDLINE]

16:

Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.

Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.

Cancer. 2004 Mar 15;100(6):1162-70.

PMID: 15022282 [PubMed - indexed for MEDLINE]

17:

Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis.

Larsen PD, Bloomer LC, Bray PF.

Neurology. 1985 Mar;35(3):435-8.

PMID: 2983262 [PubMed - indexed for MEDLINE]

19:

Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.

Berkel AI, Henle W, Henle G, Ersoy F, Sanal O, Klein G, Yeğin O.

Kroc Found Ser. 1985;19:287-300.

PMID: 2999343 [PubMed - indexed for MEDLINE]

20:

Association of -592C/A, -819C/T and -1082A/G interleukin-10 promoter polymorphisms with idiopathic recurrent spontaneous abortion.

Zammiti W, Mtiraoui N, Cochery-Nouvellon E, Mahjoub T, Almawi WY, Gris JC.

Mol Hum Reprod. 2006 Dec;12(12):771-6. Epub 2006 Oct 13.

PMID: 17041236 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 101
of 6Next